Description
The global industrial rhamnolipid market was valued at USD 467.7 million in 2025 and is expected to reach USD 822.6 million by 2032, growing at a CAGR of 8.4% during 2026-2032. Rhamnolipids are biosurfactants produced primarily through microbial fermentation and are increasingly being adopted as bio-based alternatives to conventional petrochemical surfactants. Their combination of surface activity, biodegradability, formulation compatibility, and relatively low environmental persistence is supporting their adoption across industrial applications. The market is being driven particularly by rising use in enhanced oil recovery, growing applications in cosmetics and personal care, and increasing demand for environmentally compatible and biodegradable surfactants. Improvements in fermentation control, microbial strain optimization, feedstock utilization, and downstream processing are also improving the consistency and scalability of commercial rhamnolipid production. These developments are helping transition rhamnolipids from specialty biosurfactants into broader industrial inputs capable of meeting performance, sustainability, and regulatory requirements.
Industrial adoption is expanding beyond conventional surface-active applications toward oilfield chemistry, agricultural formulations, environmental remediation, industrial and institutional cleaning, pharmaceuticals, healthcare, and specialty formulations. Mono-rhamnolipids currently represent the leading type, while liquid formulations account for the largest share by form because of their handling characteristics, solubility, dosing flexibility, and compatibility with continuous industrial processes. Technical-grade products remain dominant because they offer a comparatively economical option for large-volume industrial applications. Oil & gas is the largest end-use segment, supported by the use of rhamnolipids in enhanced oil recovery, drilling fluids, and well-stimulation processes. At the regional level, Asia Pacific is the largest market, supported by industrial activity, agricultural applications, energy demand, feedstock availability, and fermentation capacity, while Latin America is projected to be the fastest-growing region. Continued improvements in production economics and bioprocessing are expected to determine the pace of commercialization, particularly because high production costs and limited availability of suitable raw materials remain important constraints. At the same time, bioremediation, environmental applications, pharmaceutical formulations, and drug-delivery systems offer emerging opportunities for higher-value applications.
Key Highlights
• Mono-rhamnolipids remain the leading product type, supported by their surface activity, solubility, formulation compatibility, and established use across cleaning, oilfield chemistry, and environmental applications. Di-rhamnolipids address more specialized requirements where enhanced emulsification, stability, and durability are important.
• Liquid rhamnolipids account for the dominant form segment, as they enable convenient handling, rapid dissolution, precise dosing, and straightforward integration into industrial formulations. Ready-to-use, concentrated, and aqueous suspension formats provide flexibility for different process requirements.
• Technical-grade rhamnolipids lead the grade segment, reflecting their cost advantages and suitability for high-volume industrial applications. High-purity and ultra-high-purity products are gaining relevance in specialized formulations requiring greater consistency, safety, and formulation control.
• Oil & gas represents the largest end-use segment, supported by rhamnolipid applications in enhanced oil recovery, drilling fluids, and well stimulation. Their interfacial activity and biodegradability provide an alternative to conventional surfactants in applications facing increasing environmental scrutiny.
• Agriculture is emerging as an important application area, with rhamnolipids being explored as bio-adjuvants, soil conditioners, crop protection enhancers, and formulation components. Their compatibility with sustainable agricultural practices can support reduced reliance on conventional chemical inputs.
• Cosmetics and personal care applications are expanding, driven by demand for biodegradable and renewable surfactant ingredients. Rhamnolipids can provide cleansing, emulsification, and formulation benefits while aligning with growing consumer and brand preferences for environmentally responsible ingredients.
• Pharmaceutical and healthcare applications represent a higher-value opportunity, particularly in antimicrobial formulations and drug-delivery systems. Increasing research into biosurfactant functionality could broaden their role beyond conventional surfactant applications.
• Environmental remediation is an emerging opportunity, particularly because rhamnolipids can improve the mobilization and removal of hydrophobic contaminants. Their biodegradability and biological origin make them attractive for remediation approaches where environmental compatibility is important.
• Growing demand for eco-friendly and biodegradable surfactants is strengthening market adoption, as manufacturers and end users seek alternatives to persistent petrochemical-based materials. Sustainability targets and increasing environmental scrutiny are encouraging companies to reassess conventional formulation inputs.
• Enhanced oil recovery remains a key commercial growth driver, as rhamnolipids can reduce interfacial tension and improve interactions between oil, water, and reservoir surfaces. Their potential environmental advantages can further support adoption in selected oilfield applications.
• Advances in industrial biotechnology are improving commercial feasibility, with fermentation optimization, microbial strain engineering, process control, and downstream purification helping improve production consistency and scalability.
• Production economics remain a significant challenge, as fermentation-based manufacturing can involve higher costs than established petrochemical surfactant production. Improving yields, feedstock utilization, process efficiency, and purification economics will be important for broader commercialization.
• Raw-material availability can influence supply reliability, particularly where suitable feedstocks are limited or exposed to price volatility. Greater feedstock diversification and improved microbial conversion efficiency can help reduce this constraint.
• Industrial customers are increasingly incorporating sustainability into procurement decisions, creating opportunities for rhamnolipids to replace conventional surfactants in applications where performance and environmental characteristics must be considered together.
• Asia Pacific represents the largest regional market, supported by strong industrial activity, agricultural applications, energy-related demand, expanding cleaning applications, and access to feedstocks and fermentation capabilities.
• Latin America is expected to be the fastest-growing regional market, supported by increasing applications across energy, agriculture, and environmental management. Brazil, Mexico, and Argentina represent important markets within the region.
• North America represents a significant market for industrial rhamnolipids, supported by applications across energy production, industrial cleaning, environmental protection, and specialty formulations. The U.S. remains the dominant country market within the region.
• Europe is supported by stringent environmental requirements and sustainability objectives, encouraging the adoption of biodegradable materials and circular-economy-oriented solutions. Demand is also supported by applications in cleaning, personal care, and specialty industrial formulations.
• Middle East & Africa provide opportunities through energy and industrial applications, particularly where rhamnolipids can support oilfield processes and environmental management. Saudi Arabia, South Africa, and the UAE are key markets within the regional landscape.
• The competitive landscape includes established chemical manufacturers and specialized biotechnology companies, with players differentiating through fermentation capabilities, product purity, application expertise, production scale, and downstream processing technologies.
• The Dow Chemical Company is identified by GMI as the market leader, accounting for more than 14% of market share in 2025. Evonik Industries, Stepan Company, AGAE Technologies, Jeneil Biotech, and Holiferm are among the other prominent participants.
• The top five players collectively accounted for approximately 43% of the market in 2025, indicating a relatively consolidated competitive environment while leaving meaningful opportunities for regional specialists, technology providers, and emerging biosurfactant producers.
• Evonik’s industrial-scale rhamnolipid production expansion is an important industry development, demonstrating the transition of biosurfactants from laboratory and specialty production toward large-scale commercial manufacturing.
• Future market development will depend heavily on production scalability and cost reduction, particularly through improved fermentation yields, strain engineering, downstream processing, feedstock optimization, and process automation.
Key Company Profiles
• Evonik Industries AG
• Stepan Company
• AGAE Technologies LLC
• Jeneil Biotech Inc
• Holiferm Ltd
• GlycoSurf
• Zhejiang Silver Elephant Bio-engineering Co. Ltd
• Shaanxi Deguan Biotechnology Co. Ltd
• Starchem Enterprises Limited
• Xi’an Rege Biotechnology Co., Ltd.
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
